R&D

Target-loaded EV

Exo-siR · Exo-Pro · Exo-Chem

Our target-loaded EVs have a high potential to be applied for infinite pipelines depending on the source of EVs (cell-derived, food-derived, or bacteria-derived) and cargo materials (siRNA, protein, chemical, etc.).

Target-loaded EVs are classified into Exo-siR (siRNA-loaded EV), Exo-Pro (protein-loaded EV), and Exo-Chem (chemical-loaded EV) according to the type of target loaded.

Exo-siR

siRNA-loaded EV

Exo-Pro

Protein-loaded EV

Exo-Chem

Chemical-loaded EV

Pipelines

Pipelines

The SWEET™ platform helps you develop potential treatments for unmet, high-demand diseases.

CANDIDATE
INDICATION
SOURCE / ROUTE
DISCOVERYPRECLINICALPHASE I

PDAC: pancreatic ductal adenocarcinoma · CRC: colorectal cancer · IBD: inflammatory bowel disease

EB-TM1 Milestones

KRAS siRNA-Loaded EV

  • 2024.04Non-clinical efficacy confirmed (BioSpectator)
  • 2024.03Preclinical results presented at AACR 2024
  • 2023.12Selected for the KDDF candidate derivation program

Newschevron_right

Latest news and press coverage of Exollence.

Noticechevron_right

Shareholder meeting notices and announcements.

Pipelineschevron_right

EB-TM1, EB-PO1 and EB-Vac1 development status.

Contactchevron_right

Discuss EV supply and API loading services.